Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
Fuji
Baxter
Boehringer Ingelheim
Medtronic
Chinese Patent Office
Mallinckrodt
Moodys
Johnson and Johnson

Generated: December 18, 2018

DrugPatentWatch Database Preview

Sarepta Theraps Inc Company Profile

« Back to Dashboard

What is the competitive landscape for SAREPTA THERAPS INC, and what generic alternatives to SAREPTA THERAPS INC drugs are available?

SAREPTA THERAPS INC has one approved drug.

There are five US patents protecting SAREPTA THERAPS INC drugs.

There are one hundred and sixty patent family members on SAREPTA THERAPS INC drugs in twenty-three countries.

Summary for Sarepta Theraps Inc
International Patents:160
US Patents:5
Tradenames:1
Ingredients:1
NDAs:1

Drugs and US Patents for Sarepta Theraps Inc

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sarepta Theraps Inc EXONDYS 51 eteplirsen SOLUTION;INTRAVENOUS 206488-002 Sep 19, 2016 RX Yes Yes ➤ Sign Up ➤ Sign Up
Sarepta Theraps Inc EXONDYS 51 eteplirsen SOLUTION;INTRAVENOUS 206488-002 Sep 19, 2016 RX Yes Yes 8,486,907 ➤ Sign Up Y ➤ Sign Up
Sarepta Theraps Inc EXONDYS 51 eteplirsen SOLUTION;INTRAVENOUS 206488-001 Sep 19, 2016 RX Yes Yes 9,243,245 ➤ Sign Up Y ➤ Sign Up
Sarepta Theraps Inc EXONDYS 51 eteplirsen SOLUTION;INTRAVENOUS 206488-002 Sep 19, 2016 RX Yes Yes 9,416,361 ➤ Sign Up Y ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
AstraZeneca
QuintilesIMS
US Department of Justice
Harvard Business School
US Army
Teva
Deloitte
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.